Furthermore, our preliminary studies showed that treatment with Cl-amidine (PAD inhibitor) resulted in suppression of arthritis coupled with a significant decrease in serum citrullinated ITIH4 levels, although there was no significant decrease in ACPA titers in pGIA. The gene discussed is PRTN3; the disease is Arthritis.